Invention Grant
- Patent Title: JAK inhibitor and use thereof
-
Application No.: US16966112Application Date: 2019-01-31
-
Publication No.: US11427581B2Publication Date: 2022-08-30
- Inventor: Weiwei Mao , Hao Wu , Xuejian Zheng , Guoping Hu , Changqing Wei , Jian Li , Shuhui Chen
- Applicant: ZHUHAI UNITED LABORATORIES CO., LTD.
- Applicant Address: CN Guangdong
- Assignee: ZHUHAI UNITED LABORATORIES CO., LTD.
- Current Assignee: ZHUHAI UNITED LABORATORIES CO., LTD.
- Current Assignee Address: CN Guangdong
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: CN201810096070.X 20180131,CN201810967605.6 20180823
- International Application: PCT/CN2019/074145 WO 20190131
- International Announcement: WO2019/149244 WO 20190808
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P19/02 ; C07D513/04
Abstract:
Disclosed in the present application are a class of compounds as JAK inhibitors and use thereof in the preparation of medicaments for treating JAK and TYK2 related diseases. Specifically, a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof is disclosed.
Public/Granted literature
- US20210070754A1 JAK INHIBITOR AND USE THEREOF Public/Granted day:2021-03-11
Information query
